FORT COLLINS, Colo., March 24, 2022 (GLOBE NEWSWIRE) — Statera Biopharma, Inc. (NASDAQ: STAB) (the “Company” or “Statera Biopharma”), a leading biopharmaceutical company creating next-generation …
The SPAC Conference – June 15 & 16, 2022
Sichenzia Ross Ference is a proud sponsor of The SPAC Conference 2022. Join us June 15 and 16th at the West Chester Country Club in Rye, NY. The SPAC Conference brings together the leading …
Continue Reading about The SPAC Conference – June 15 & 16, 2022 →
Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $10 Million Underwritten Public Offering for Tantech Holdings Ltd.
Press Release – New York, NY – March 21, 2022 – Sichenzia Ross Ference LLP today announced that it represented Aegis Capital Corp. as sole book runner in an underwritten public offering of Tantech …
CMF Represents Nano Technologies Inc. In $4,570,000 Private Placement
Sichenzia Ross Ference LLP Represents Sunshine Biopharma, Inc. in $8 Million Private Placement
Press Release – New York, NY – March 15, 2022 – Sichenzia Ross Ference LLP today announced that it represented Sunshine Biopharma, Inc., a pharmaceutical company focused on the research, development …
CMF Represents Cosmos Holdings Inc. In $6 Million Pipe And Nasdaq Uplisting
CHICAGO, ILLINOIS – Feb. 28, 2022 (GLOBE NEWSWIRE) — Carmel, Milazzo & Feil LLP (“CMF”) announced today that it has represented Cosmos Holdings, Inc. (“the Company”) (Nasdaq: COSM), an …
Continue Reading about CMF Represents Cosmos Holdings Inc. In $6 Million Pipe And Nasdaq Uplisting →
